Hansoh Pharma vies for IPO attention amid biotech frenzy
The Jiangsu-based generic drug maker has started to bookbuild for a $1 billion IPO in Hong Kong, hoping to grab attention while the local exchange is focused on biotech firms.
May 30, 2019
